In later experiments in patients with advanced solid tumors, an increase in the expression of ISGs and an enrichment of the immune response gene, accompanied by an increment in CD8+ T cells, was observed on tumor biopsies after the use of RBN-2397 (150). Here, CD8A is linked to neoplasm.